Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$191M |
| 2 |
Nike
NKE
|
+$190M |
| 3 |
UnitedHealth
UNH
|
+$158M |
| 4 |
Shopify
SHOP
|
+$153M |
| 5 |
TSMC
TSM
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$910M |
| 2 |
Microsoft
MSFT
|
+$668M |
| 3 |
Meta Platforms (Facebook)
META
|
+$351M |
| 4 |
Micron Technology
MU
|
+$244M |
| 5 |
Apple
AAPL
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.86% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Financials | 8.97% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IRD
3201
Opus Genetics
IRD
$309M
| $173K | ﹤0.01% |
145,509
+74,900
| +106% | +$86K |
|
3202
Paramount Gold Nevada
PZG
$127M
| $171K | ﹤0.01% |
499,972
-122,457
| -20% | -$47.5K |
|
|
GATO
3203
DELISTED
Gatos Silver, Inc.
GATO
| $171K | ﹤0.01% |
+12,200
| New | +$199K |
|
3204
BlackSky Technology
BKSY
$1.27B
| $170K | ﹤0.01% |
+15,800
| New | +$135K |
|
|
SPRB
3205
Spruce Biosciences
SPRB
$143M
| $170K | ﹤0.01% |
5,412
-2,717
| -33% | -$99.6K |
|
3206
NSTS Bancorp
NSTS
$66.8M
| $170K | ﹤0.01% |
+14,400
| New | +$160K |
|
|
FPI
3207
Farmland Partners
FPI
$425M
| $169K | ﹤0.01% |
+14,400
| New | +$169K |
|
3208
Research Frontiers
REFR
$15.2M
| $168K | ﹤0.01% |
98,069
+24,969
| +34% | +$48.9K |
|
3209
Kyverna Therapeutics
KYTX
$500M
| $167K | ﹤0.01% |
+44,700
| New | +$214K |
|
|
TRIB
3210
Trinity Biotech
TRIB
$8.01M
| $166K | ﹤0.01% |
6,302
-2,036
| -24% | -$81.7K |
|
|
CYPH
3211
Cypherpunk Technologies Inc
CYPH
$69.8M
| $166K | ﹤0.01% |
57,650
+17,800
| +45% | +$52.9K |
|
|
SVMH
3212
DELISTED
SRIVARU Holding Limited Ordinary Shares
SVMH
| $165K | ﹤0.01% |
+78,620
| New | +$172K |
|
3213
Rapid Micro Biosystems
RPID
$85.3M
| $165K | ﹤0.01% |
183,087
+100,942
| +123% | +$102K |
|
3214
Soluna Holdings
SLNH
$205M
| $164K | ﹤0.01% |
77,900
-67,800
| -47% | -$225K |
|
3215
Verrica Pharmaceuticals
VRCA
$83.5M
| $163K | ﹤0.01% |
23,330
+8,534
| +58% | +$93.8K |
|
3216
PDS Biotechnology
PDSB
$13M
| $163K | ﹤0.01% |
100,000
+76,800
| +331% | +$203K |
|
3217
Bolt Biotherapeutics
BOLT
$6.17M
| $162K | ﹤0.01% |
15,102
+400
| +3% | +$4.84K |
|
|
GRCE
3218
Grace Therapeutics
GRCE
$43.5M
| $161K | ﹤0.01% |
42,975
+26,828
| +166% | +$91.9K |
|
|
KLRS
3219
Kalaris Therapeutics
KLRS
$92.4M
| $159K | ﹤0.01% |
16,503
-17,273
| -51% | -$261K |
|
|
CMCT
3220
Creative Media & Community Trust
CMCT
$15M
| $157K | ﹤0.01% |
28
+26
| +1,300% | +$234K |
|
|
BCOW
3221
DELISTED
1895 Bancorp of Wisconsin
BCOW
| $155K | ﹤0.01% |
15,500
-400
| -3% | -$4.01K |
|
3222
Arcutis Biotherapeutics
ARQT
$3.25B
| $155K | ﹤0.01% |
11,099
-181,000
| -94% | -$1.98M |
|
|
BBBY
3223
Bed Bath & Beyond
BBBY
$423M
| $153K | ﹤0.01% |
+34,210
| New | +$218K |
|
3224
CalciMedica
CALC
$20.2M
| $153K | ﹤0.01% |
+43,200
| New | +$151K |
|
|
CMCM
3225
Cheetah Mobile
CMCM
$94.7M
| $152K | ﹤0.01% |
33,045
-400
| -1% | -$1.92K |
|
Similar funds
Jim Simons's Q4 2024 Portfolio in Review
As of Q4 2024, Jim Simons held 4,032 positions worth $67.6B, up 1.6% from $66.5B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Jim Simons's Q4 2024 filing shows 548 new, 1,485 increased, 1,480 reduced and 497 closed positions. Its largest new stake was UnitedHealth: 278,658 shares worth $141M. The largest sale was Palantir, an estimated $910M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2024 buy was UnitedHealth: 278,658 shares worth $141M.
- Jim Simons added most to Alibaba in Q4 2024, an estimated $191M increase.
- Jim Simons's biggest Q4 2024 reduction was Palantir, cutting an estimated $910M.
- Jim Simons fully exited Arm in Q4 2024, selling an estimated $153M.
- Jim Simons's ten largest holdings make up 10% of its $67.6B portfolio in Q4 2024.
- Jim Simons opened 548 new positions and closed 497 in Q4 2024.
- Jim Simons's portfolio value rose 1.6% quarter-over-quarter to $67.6B.
Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.